Publication | Closed Access
A multicenter phase II study of temozolomide plus disulfiram and copper for recurrent temozolomide-resistant glioblastoma
123
Citations
18
References
2019
Year
Neuro-oncologyOncologyRecurrent Temozolomide-resistant GlioblastomaMedicineAnti-cancer AgentHigh-grade GliomasCancer TreatmentRadiation OncologyPharmacologyGlioma
| Year | Citations | |
|---|---|---|
Page 1
Page 1